Assembly Biosciences (ASMB) Curent Deferred Tax Liability (2014 - 2019)

Assembly Biosciences' Curent Deferred Tax Liability history runs 6 years deep, the most recent figure standing at $3.3 million for Q1 2019.

• In Q1 2019, Curent Deferred Tax Liability rose 52.26% year-over-year to $3.3 million; the TTM figure through Mar 2019 stood at $3.3 million (up 52.26% YoY), while the FY2018 annual figure was $3.3 million, up 52.25% from the prior year.
• Curent Deferred Tax Liability was $3.3 million for Q1 2019 at Assembly Biosciences, roughly flat from $3.3 million in the prior quarter.
• In the past five years, Curent Deferred Tax Liability ranged from a high of $11.6 million in Q1 2015 to a low of $2.1 million in Q3 2018.
• Historically, Curent Deferred Tax Liability has averaged $8.3 million across 5 years, with a median of $11.1 million in 2017.
• The sharpest annual moves came in 2018 and 2019: Curent Deferred Tax Liability tumbled 81.13% in 2018, then soared 52.26% in 2019.
• A 5-year view of Curent Deferred Tax Liability shows it stood at $11.6 million in 2015, then dropped by 4.14% to $11.1 million in 2016, then plunged by 80.79% to $2.1 million in 2017, then soared by 52.25% to $3.3 million in 2018, then changed by 0.0% to $3.3 million in 2019.
• The last three Curent Deferred Tax Liability figures came in at $3.3 million (Q1 2019), $3.3 million (Q4 2018), and $2.1 million (Q3 2018), per Business Quant data.